Clinical trial · Observational
Application and Clinical Effectiveness of Pelvic Reconstruction in Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder in the Male
NCT04958343CI-TRIAL-00052637unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To study the effect of pelvic reconstruction on early return of continence after robot-assisted radical cystectomy-orthotopic ileal neobladder in the male.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| pelvic reconstruction | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- reconstruction group
- description
- Patients will receive pelvic reconstruction following radical cystectomy during the operation.
- interventionNames
- Procedure: pelvic reconstruction
- label
- non-reconstruction group
- description
- Patients will not receive pelvic reconstruction following radical cystectomy during the operation.
Primary outcomes (1)
- measure
- day-time and night-time continence rate
- timeFrame
- 6 months
- description
- Patients were considered continent when they required 0 or 1 safety pad during the day or at night.
Secondary outcomes (5)
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Male patients aged 18 or older. 2. Patients those who are diagnosed with urothelial carcinoma. 3. Patients those who are capable of receiving radical cystectomy with orthotopic ileal neobladder. 4. Patients those who are able to cooperate and complete the follow-up. 5. Patients those who volunteer to participate in this study and sign the informed consens. Exclusion Criteria: 1. Patients thsoe who are diagnosed distant metastasis before surgery. 2. Patients those who are diagnosed with other malignancies. 3. Patients those who had received pelvic radiotherapy or major pelvic operation.
References
Publications (0)
Data not yet available
No reference posted for this study.